<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34994473</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1600-0536</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>86</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Contact dermatitis</Title>
          <ISOAbbreviation>Contact Dermatitis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Acute generalized exanthematous pustulosis due to a transdermal ketoprofen patch.</ArticleTitle>
        <Pagination>
          <StartPage>425</StartPage>
          <EndPage>427</EndPage>
          <MedlinePgn>425-427</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cod.14044</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Katayama</LastName>
            <ForeName>Sho</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-0188-3717</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Chitose City Hospital, Chitose, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ota</LastName>
            <ForeName>Mitsuhito</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-1987-4555</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Chitose City Hospital, Chitose, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Contact Dermatitis</MedlineTA>
        <NlmUniqueID>7604950</NlmUniqueID>
        <ISSNLinking>0105-1873</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>90Y4QC304K</RegistryNumber>
          <NameOfSubstance UI="D007660">Ketoprofen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D056150" MajorTopicYN="Y">Acute Generalized Exanthematous Pustulosis</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017449" MajorTopicYN="Y">Dermatitis, Allergic Contact</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007660" MajorTopicYN="Y">Ketoprofen</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010328" MajorTopicYN="N">Patch Tests</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">acute generalized exanthematous pustulosis</Keyword>
        <Keyword MajorTopicYN="Y">case report</Keyword>
        <Keyword MajorTopicYN="Y">patch test</Keyword>
        <Keyword MajorTopicYN="Y">transdermal ketoprofen patch</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>7</Day>
          <Hour>8</Hour>
          <Minute>52</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34994473</ArticleId>
        <ArticleId IdType="doi">10.1111/cod.14044</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Hadavand MA, Kaffenberger B, Cartron AM, Trinidad JC. Clinical presentation and Management of Atypical and Recalcitrant Acute Generalized Exanthematous Pustulosis (AGEP). J Am Acad Dermatol. 2020;S0190-9622(20):32609-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Aerts O, Medaer K, Vermander E, Matthieu L, Lambert J. Contact allergy with photoaggravation caused by a plaster containing ketoprofen. Contact Dermatitis. 2012;66(Suppl. 2):18-19.</Citation>
        </Reference>
        <Reference>
          <Citation>Cruz RD, Ferguson J, Wee JS, Akhras V. Acute localised exanthematous pustulosis (ALEP) induced by clindamycin in pregnancy. Australas J Dermatol. 2015;56(3):e55-e58.</Citation>
        </Reference>
        <Reference>
          <Citation>Beltran C, Vergier B, Doutre MS, Beylot C, Beylot-Barry M. Acute generalized exanthematous pustulosis induced by topical application of Algipan. Ann Dermatol Venereol. 2009;136(10):709-712.</Citation>
        </Reference>
        <Reference>
          <Citation>Belhadjali H, Ghannouchi N, Njim L, et al. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl. Contact Dermatitis. 2008;58(4):247-248.</Citation>
        </Reference>
        <Reference>
          <Citation>Mashiah J, Brenner S. A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol. 2003;139(9):1181-1183.</Citation>
        </Reference>
        <Reference>
          <Citation>Barbaud A, Collet E, Milpied B, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol. 2013;168(3):555-562.</Citation>
        </Reference>
        <Reference>
          <Citation>Salman A, Yucelten D, Akin Cakici O, Kepenekli KE. Acute generalized exanthematous pustulosis due to ceftriaxone: report of a pediatric case with recurrence after positive patch test. Pediatr Dermatol. 2019;36(4):514-516.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
